Baird raises target for Cencora stock to USD 373.00
Published on 10/16/2026 at 10:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSTarget raise and earnings path
- Robert W. Baird lifted its Cencora target from USD 370.00 to USD 373.00 on October 12, 2026.
- Fiscal third-quarter revenue reached USD 84.75 billion, up 5.10 percent year over year.
- Cencora stock trades at EUR 304.70 at 10:34 a.m. CEST at Lang & Schwarz on October 16, 2026.
Cencora Inc. (ISIN US03073E1055) was trading at EUR 304.70 at Lang & Schwarz on October 16, 2026 at 10:34 a.m. CEST. Robert W. Baird raised its target from USD 370.00 to USD 373.00 on October 12, 2026, according to MarketBeat. The move keeps an outperform rating in place.
Fiscal third-quarter numbers matter
Cencora reported USD 84.75 billion in fiscal third-quarter revenue, an increase of 5.10 percent from the prior-year quarter. Adjusted earnings per share reached USD 4.48 against a USD 4.35 consensus estimate, according to Benzinga.
The company also raised fiscal 2026 adjusted earnings-per-share guidance to USD 17.75-17.95 from USD 17.70-17.90. That combination of revenue growth, an earnings comparison and higher guidance gives the analyst target its immediate operating context.
Three dated steps shaped the stock
On August 5, 2026, Cencora reported fiscal third-quarter revenue of USD 84.75 billion and adjusted earnings per share of USD 4.48, as MarketBeat reported. On October 12, 2026, Robert W. Baird raised its target to USD 373.00 from USD 370.00. On October 16, 2026, the Lang & Schwarz quote stood at EUR 304.70.
What date comes next?
Cencora plans to release fiscal fourth-quarter 2026 results before the New York Stock Exchange opens on November 4, 2026, and will host its conference call at 8:30 a.m. ET, according to Cencora. The date places the next full-year outlook update close to the analyst target revision.
Stock price and investor perspective
The October 16, 2026 euro quote puts the market focus on whether the next report can support the raised fiscal 2026 earnings range. Cencora combines pharmaceutical distribution with commercialization, specialty logistics and patient-access services, while its fiscal third-quarter numbers provide the latest operating baseline.
Cencora stock was trading at EUR 304.70 at Lang & Schwarz on October 16, 2026 at 10:34 a.m. CEST.
The further course of trading is shown by the continuously updated real-time quote of Cencora stock.
Cencora stock at a glance
- Company: Cencora, Inc.
- ISIN: US03073E1055
- Ticker: COR
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 16, 2026, 10:34 a.m. CEST): EUR 304.70
- Market capitalization: USD 62.1 billion (as of October 12, 2026)
- 52-week range: USD 244.82-377.54 (as of October 12, 2026)
- Sector / Industry: Healthcare / Medical Distribution
- Index membership: S&P 500
- Next earnings date: November 4, 2026
Market context: Market report S&P 500.
